Profile | GDS5420 / 242239_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 98.9 | 41 |
GSM1296119 | B_lesional_pre-dose | 96.55 | 39 |
GSM1296076 | C_lesional_pre-dose | 81.86 | 39 |
GSM1296092 | D_lesional_pre-dose | 51.84 | 34 |
GSM1296103 | E_lesional_pre-dose | 55.05 | 33 |
GSM1296078 | F_lesional_pre-dose | 61.82 | 35 |
GSM1296107 | G_lesional_pre-dose | 91.46 | 38 |
GSM1296109 | H_lesional_pre-dose | 88.62 | 38 |
GSM1296080 | I_lesional_pre-dose | 101.03 | 43 |
GSM1296090 | J_lesional_pre-dose | 64.81 | 36 |
GSM1296074 | K_lesional_pre-dose | 38.95 | 29 |
GSM1296111 | L_lesional_pre-dose | 87.72 | 37 |
GSM1296099 | M_lesional_pre-dose | 33.01 | 25 |
GSM1296086 | O_lesional_pre-dose | 48.82 | 32 |
GSM1296117 | P_lesional_pre-dose | 119.9 | 42 |
GSM1296113 | Q_lesional_pre-dose | 139.75 | 44 |
GSM1296096 | R_lesional_pre-dose | 68.81 | 36 |
GSM1296105 | S_lesional_pre-dose | 100.86 | 41 |
GSM1296098 | T_lesional_pre-dose | 102.13 | 41 |
GSM1296101 | U_lesional_pre-dose | 83.6 | 38 |
GSM1296121 | V_lesional_pre-dose | 56.2 | 31 |
GSM1296088 | W_lesional_pre-dose | 74.43 | 38 |
GSM1296082 | X_lesional_pre-dose | 68.07 | 37 |
GSM1296115 | Y_lesional_pre-dose | 81.11 | 37 |
GSM1296084 | Z_lesional_pre-dose | 84.53 | 39 |
GSM1296072 | B_lesional_day8 | 106.6 | 41 |
GSM1296069 | L_lesional_day8 | 91.78 | 37 |
GSM1296071 | P_lesional_day8 | 155.05 | 46 |
GSM1296070 | Y_lesional_day8 | 115.52 | 41 |
GSM1296073 | V_lesional_day8 | 58.3 | 32 |
GSM1296034 | A_lesional_day15 | 178.51 | 49 |
GSM1296041 | G_lesional_day15 | 102.41 | 40 |
GSM1296035 | R_lesional_day15 | 59.11 | 35 |
GSM1296038 | U_lesional_day15 | 61.65 | 34 |
GSM1296047 | B_lesional_day15 | 104.05 | 40 |
GSM1296039 | E_lesional_day15 | 50.34 | 31 |
GSM1296042 | H_lesional_day15 | 129.36 | 43 |
GSM1296043 | L_lesional_day15 | 122.64 | 42 |
GSM1296037 | M_lesional_day15 | 133.46 | 45 |
GSM1296046 | P_lesional_day15 | 113.27 | 41 |
GSM1296044 | Q_lesional_day15 | 171.63 | 48 |
GSM1296045 | Y_lesional_day15 | 136.47 | 43 |
GSM1296025 | C_lesional_day15 | 122.6 | 45 |
GSM1296033 | D_lesional_day15 | 98 | 42 |
GSM1296027 | I_lesional_day15 | 105.16 | 44 |
GSM1296032 | J_lesional_day15 | 181.46 | 51 |
GSM1296024 | K_lesional_day15 | 111.51 | 44 |
GSM1296031 | W_lesional_day15 | 131.49 | 45 |
GSM1296028 | X_lesional_day15 | 111.15 | 43 |
GSM1296029 | Z_lesional_day15 | 119.12 | 44 |
GSM1296026 | F_lesional_day15 | 65.6 | 35 |
GSM1296030 | O_lesional_day15 | 90.54 | 43 |
GSM1296040 | S_lesional_day15 | 105.15 | 42 |
GSM1296036 | T_lesional_day15 | 135.17 | 45 |
GSM1296048 | V_lesional_day15 | 81.51 | 37 |
GSM1296059 | A_lesional_day43 | 73.15 | 38 |
GSM1296066 | G_lesional_day43 | 128.37 | 43 |
GSM1296060 | R_lesional_day43 | 63.12 | 35 |
GSM1296063 | U_lesional_day43 | 83.52 | 38 |
GSM1296064 | E_lesional_day43 | 47.86 | 31 |
GSM1296067 | H_lesional_day43 | 135.03 | 44 |
GSM1296062 | M_lesional_day43 | 121.27 | 44 |
GSM1296068 | Q_lesional_day43 | 164.14 | 46 |
GSM1296050 | C_lesional_day43 | 163.08 | 49 |
GSM1296057 | D_lesional_day43 | 84.77 | 39 |
GSM1296052 | I_lesional_day43 | 128.92 | 47 |
GSM1296054 | J_lesional_day43 | 281.31 | 57 |
GSM1296049 | K_lesional_day43 | 112.61 | 44 |
GSM1296055 | W_lesional_day43 | 94.82 | 39 |
GSM1296053 | X_lesional_day43 | 126.8 | 45 |
GSM1296058 | Z_lesional_day43 | 64.21 | 36 |
GSM1296051 | F_lesional_day43 | 73.96 | 37 |
GSM1296056 | O_lesional_day43 | 36.61 | 28 |
GSM1296065 | S_lesional_day43 | 77.33 | 37 |
GSM1296061 | T_lesional_day43 | 107.25 | 42 |
GSM1296095 | A_non-lesional_pre-dose | 88.98 | 40 |
GSM1296120 | B_non-lesional_pre-dose | 120.97 | 42 |
GSM1296077 | C_non-lesional_pre-dose | 163.02 | 50 |
GSM1296093 | D_non-lesional_pre-dose | 204.26 | 52 |
GSM1296104 | E_non-lesional_pre-dose | 21.66 | 17 |
GSM1296079 | F_non-lesional_pre-dose | 106.49 | 43 |
GSM1296108 | G_non-lesional_pre-dose | 160.88 | 48 |
GSM1296110 | H_non-lesional_pre-dose | 149.78 | 45 |
GSM1296081 | I_non-lesional_pre-dose | 176.65 | 52 |
GSM1296091 | J_non-lesional_pre-dose | 107.96 | 44 |
GSM1296075 | K_non-lesional_pre-dose | 85.96 | 40 |
GSM1296112 | L_non-lesional_pre-dose | 158.32 | 46 |
GSM1296100 | M_non-lesional_pre-dose | 163.74 | 48 |
GSM1296087 | O_non-lesional_pre-dose | 168.59 | 52 |
GSM1296118 | P_non-lesional_pre-dose | 217.67 | 52 |
GSM1296114 | Q_non-lesional_pre-dose | 171.15 | 48 |
GSM1296097 | R_non-lesional_pre-dose | 98.8 | 41 |
GSM1296106 | S_non-lesional_pre-dose | 96.72 | 39 |
GSM1296102 | U_non-lesional_pre-dose | 180.91 | 49 |
GSM1296122 | V_non-lesional_pre-dose | 165.27 | 48 |
GSM1296089 | W_non-lesional_pre-dose | 121.06 | 43 |
GSM1296083 | X_non-lesional_pre-dose | 182.11 | 51 |
GSM1296116 | Y_non-lesional_pre-dose | 162.3 | 46 |
GSM1296085 | Z_non-lesional_pre-dose | 140.07 | 47 |